| 06/24/2008 | Caris Diagnostics Providing KRAS Mutational Analysis for Colon Cancer Patients |
Providing Information on Response to Erbitux® and Vectibix®
Caris Diagnostics (Caris Dx), a leading provider of the highest quality diagnostic, translational development and pharmaceutical services encompassing anatomic pathology and molecular testing, announced that it is now offering KRAS mutation analysis, designed to provide information on which colon cancer patients are most likely to respond to cetuximab (Erbitux) co-marketed by ImClone and Bristol-Myers Squibb or panitumumab (Vectibix) developed by Amgen. Read more >>
| 04/15/2008 | Two New Therapies Show Promise for Cancer Patients |
Clinical trial data and cutting-edge testing give key insights in the fight against basal cell carcinoma and pancreatic cancer. Clinical researchers at Scottsdale Healthcare and TGen today announced the results of two clinical trials that show promise for patients battling cancer. Read more >>
| 02/06/2008 | Research Demonstrates Tracking Quality Indicators is of Critical Importance to Gastroenterologists |
Nearly nine in ten (88%) gastroenterologists either currently capture Quality Indicator (QI) data or plan to do so in the next two years, according to a January 2008 independent, national survey of gastroenterologists commissioned by ProVation Medical and Caris Diagnostics. Of those surveyed who collect QI data, majorities cited colonoscopic withdrawal time (62%) and rate of adenomatous polyp detection (52%) as indicators they capture most frequently. Read more >>
| 01/15/2008 | Caris Diagnostics Announces Addition of Leading Dermatopathologist to Expand Subspecialty Expertise |
Caris Diagnostics, a leading provider of diagnostic services in anatomic pathology and molecular testing, today announced the hiring of another nationally-renowned dermatopathologist for its Phoenix laboratory. Iftikhar "Ifty" Ahmed, M.D. has joined Caris Diagnostics to support the growing dermatopathology practice for the company. Read more >>
| 12/06/2007 | Caris Diagnostics Announces Combination with Molecular Profiling Institute |
Caris Diagnostics, the leading provider of subspecialty focused pathology services to outpatient physicians, today announced that it has entered into a definitive agreement to combine with Molecular Profiling Institute, Inc. and its subsidiary, the Tissue Banking and Analysis Center, Inc. (“MPI”), a CLIA certified molecular diagnostics company focused on the development and commercialization of novel molecular diagnostic tests based on genomic and proteomic profiling. Read more >>
| 07/25/2007 | Caris Diagnostics Announces Expansion in Dermatopathology |
Caris Diagnostics, the leading provider of subspecialty focused pathology services to outpatient physicians, today announced that it has entered into a definitive agreement to combine with Molecular Profiling Institute, Inc. and its subsidiary, the Tissue Banking and Analysis Center, Inc. (“MPI”), a CLIA certified molecular diagnostics company focused on the development and commercialization of novel molecular diagnostic tests based on genomic and proteomic profiling. Read more >>
| 06/04/2007 | Caris Diagnostics Announces Combination with Cohen Dermatopathology |
Caris Diagnostics, the leading provider of pathology services to outpatient GI physicians, today announced that it has consummated a merger with Cohen Dermatopathology, a leading provider of pathology services relating to dermatologic conditions in the New England marketplace. Read more >>
| 05/24/2007 | Caris Diagnostics Announces Opening of Phoenix Laboratory |
Caris Diagnostics, the leading provider of pathology services to outpatient GI physicians, today announced that it recently launched its newest laboratory in Phoenix, Arizona. This 24,000 square foot, state-of-the-art facility is located in the Cotton Center, which is centrally located and offers close proximity to the airport and major roadways. Read more >>
| 05/14/2007 | Caris Diagnostics Announces The Addition of Four Nationally Renowned GI Pathologists |
Caris Diagnostics, the leading provider of pathology services to outpatient GI physicians, today announced the expansion of its clinical team through the addition of four highly-respected and accomplished GI pathologists: Robert M. Genta, M.D.; Yogeshwar Dayal, M.D.; Mukunda B. Ray, M.D., PhD.; and Shari L. Taylor, M.D. With these additions, Caris Pathology will have over 20 sub-specialty fellowship and expert-trained pathologists in gastrointestinal and liver pathology. Read more >>
| 11/14/2006 | Dr. George Poste Joins Board of Directors of Caris Diagnostics and Joins Caris, Ltd. as Senior Technical Advisor |
Caris Diagnostics, previously Pathology Partners, today announced that George Poste, D.V.M., Ph.D, F.R.C. Path, F.R.S., has joined its Board of Directors as an outside director. As well, Dr. Poste is serving as Senior Technical Advisor to Caris, Ltd., which owns a controlling stake in Caris Diagnostics. Read more >>
| 08/25/2006 | Caris Diagnostics Announces New Chief Medical Officer and Expanded Clinical Team |
Caris Diagnostics, previously Pathology Partners, today announced that it has recruited the distinguished Richard H. Lash, M.D., as its Chief Medical Officer, as well as three other industry-leading pathologists: Guy M. Lindberg, M.D., M. H. Saboorian, M.D. and James M. Gulizia, M.D., PhD. These pathologists have joined Caris Pathology, which is the new entity formed as a result of Caris Diagnostics’ integration of Metroplex Pathology Associates this summer. Read more >>
| 08/01/2006 | Pathology Partners Changes Name to Caris Diagnostics and Expands Executive Team |
Pathology Partners Inc., the industry leader in comprehensive gastrointestinal (GI) diagnostic services and technology support systems, today announced that it has undertaken an extensive review of its strategy, management and operations and has implemented significant changes to enhance the long-term benefits the company provides to its customers as well as the company’s future growth. Effective immediately, the company is changing its name to Caris Diagnostics. In addition, three key executives have joined the company this summer, following the appointment of Gail Marcus as Chief Executive Officer: Margaret Bedgood as Senior Vice President, Chief Financial Officer; Russ Farr as Senior Vice President, General Counsel; and Dr. Len Poikey as Senior Vice President, Laboratory Development. Read more >>
| 06/05/2006 | Pathology Partners Announces Hiring of Gail Marcus as New Chief Executive Officer |
Pathology Partners Inc., the industry leader in comprehensive gastrointestinal (GI) diagnostic services and technology support systems, today announced that Gail Marcus has joined the company as Chief Executive Officer. A seasoned executive in healthcare services, Marcus has over twenty years of leadership experience at United Healthcare, AdvancePCS and CIGNA Corporation. Read more >>